VBIVVBI VACCINES INC.

Nasdaq www.vbivaccines.com


$ 0.06 $ -0.07 (-50.87 %)    

Wednesday, 07-Aug-2024 15:59:54 EDT
QQQ $ 439.26 $ 0.60 (0.14 %)
DIA $ 390.53 $ 0.96 (0.25 %)
SPY $ 523.16 $ -0.95 (-0.18 %)
TLT $ 95.18 $ -0.78 (-0.81 %)
GLD $ 222.95 $ 0.22 (0.1 %)
$ 0.0653
$ 0.06 x 1,700
-- x --
-- - --
$ 0.06 - $ 1.35
28,280,883
na
555,009
$ 1.55
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-26-2016 12-31-2015 10-K
2 11-12-2015 09-30-2015 10-Q
3 07-31-2015 06-30-2015 10-Q
4 05-13-2015 03-31-2015 10-Q
5 03-20-2015 12-31-2014 10-K
6 11-14-2014 09-30-2014 10-Q
7 08-08-2014 06-30-2014 10-Q
8 05-15-2014 03-31-2014 10-Q
9 03-18-2014 12-31-2013 10-K
10 11-14-2013 09-30-2013 10-Q
11 08-19-2013 06-30-2013 10-Q
12 05-14-2013 03-31-2013 10-Q
13 03-21-2013 12-31-2012 10-K
14 11-08-2012 09-30-2012 10-Q
15 08-14-2012 06-30-2012 10-Q
16 05-14-2012 03-31-2012 10-Q
17 03-08-2012 12-31-2011 10-K
18 11-10-2011 09-30-2011 10-Q
19 08-11-2011 06-30-2011 10-Q
20 05-12-2011 03-31-2011 10-Q
21 03-10-2011 12-31-2010 10-K
22 11-15-2010 09-30-2010 10-Q
23 08-13-2010 06-30-2010 10-Q
24 05-14-2010 03-31-2010 10-Q
25 03-31-2010 12-31-2009 10-K
26 11-13-2009 09-30-2009 10-Q
27 08-12-2009 06-30-2009 10-Q
28 05-15-2009 03-31-2009 10-Q
29 03-31-2009 12-31-2008 10-K
30 11-14-2008 09-30-2008 10-Q
31 08-14-2008 06-30-2008 10-Q
32 05-15-2008 03-31-2008 10-Q
33 03-31-2008 12-31-2007 10-K
34 11-13-2007 09-30-2007 10-Q
35 08-14-2007 06-30-2007 10-Q
36 05-14-2007 03-31-2007 10-Q
37 04-02-2007 12-31-2006 10-K
38 11-20-2006 09-30-2006 10-Q
39 08-14-2006 06-30-2006 10-Q
40 05-15-2006 03-31-2006 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 vbi-vaccines-was-notified-that-its-common-shares-will-be-delisted-from-nasdaq-effective-as-of-opening-of-business-on-august-8-2024-does-not-intend-to-appeal-the-delisting-determination

On July 30, 2024, the Company received a letter from the listing qualifications department staff of the Nasdaq Stock Market LLC...

 vbi-vaccines-says-on-august-2-2024-the-us-bankruptcy-court-for-the-district-of-delaware-granted-provisional-relief-under-chapter-15-of-the-us-bankruptcy-code-and-scheduled-a-further-hearing-to-consider-the-recognition-of-the-july-30-2024-order

VBI Vaccines Inc. (NASDAQ:VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention a...

 vbi-vaccines-entered-into-a-binding-dip-facility-term-sheet-with-k2-healthventures-pursuant-to-binding-term-sheet-k2hv-has-agreed-to-make-up-to-25m-available-to-co-and-its-units

- Reuters

 vbi-vaccines-shares-resume-trade
VBI Vaccines Shares Resume Trade
07/30/2024 14:15:23

 vbi-vaccines-reports-new-tumor-response-data-from-ongoing-randomized-controlled-phase-2b-study-of-vbi-1901-for-patients-with-recurrent-glioblastoma

Among the 7 patients on VBI-1901 treatment long enough to have 1+ MRI scan at the time of analysis, one partial tumor response ...

 vbi-vaccines-to-present-new-interim-phase-2b-data-from-vbi-1901-in-recurrent-glioblastoma-patients-in-poster-presentation-at-2024-asco-annual-meeting

VBI Vaccines Inc. (NASDAQ:VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention a...

 vbi-vaccines-q1-eps-073-up-from-322-yoy-sales-121m-up-from-48500k-yoy

VBI Vaccines (NASDAQ:VBIV) reported quarterly losses of $(0.73) per share. This is a 77.33 percent increase over losses of $(3....

 why-fastenal-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter f...

 why-biophytis-shares-are-trading-higher-by-around-55-here-are-20-stocks-moving-premarket

Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION